Influence of hypertension on neurocognitive domains in nondemented Parkinson's disease patients

Parkinson's Disease

Volumn 2014, Issue , 2014, Pages

  Jones, Jacob D ^a   Jacobson, Charles ^a   Murphy, Martina ^b   Price, Catherine ^a   Okun, Michael S ^a,c   Bowers, Dawn ^a,c  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF FLORIDA HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR RISK; COGNITION; COGNITIVE DEFECT; COMORBIDITY; CROSS-SECTIONAL STUDY; DISEASE DURATION; DISEASE SEVERITY; EPISODIC MEMORY; EXECUTIVE FUNCTION; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPOTENSION; LANGUAGE ABILITY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MENTAL FUNCTION; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGY; ORTHOSTATIC HYPOTENSION; PARKINSON DISEASE; PRIORITY JOURNAL; PULSE PRESSURE; UNIFIED PARKINSON DISEASE RATING SCALE; VERBAL MEMORY; WORKING MEMORY;

EID: 84893646326     PISSN: None     EISSN: 20420080     Source Type: Journal    
DOI: 10.1155/2014/507529     Document Type: Article

References (36)

1. Alexander G. E., DeLong M. R., Strick P. L., Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annual Review of Neuroscience 1986 9 357 381 2-s2.0-0022930826
2. Chaudhuri K. R., Schapira A. H., Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment. The Lancet Neurology 2009 8 5 464 474 2-s2.0-64349083816 10.1016/S1474-4422(09)70068-7
3. Aarsland D., Andersen K., Larsen J. P., Lolk A., Nielsen H., Kragh-Sørensen P., Risk of dementia in Parkinson's disease: a community-based, Prospective Study. Neurology 2001 56 6 730 736 2-s2.0-0035957311
4. Hely M. A., Reid W. G. J., Adena M. A., Halliday G. M., Morris J. G. L., The Sydney Multicenter Study of Parkinson's disease: the inevitability of dementia at 20 years. Movement Disorders 2008 23 6 837 844 2-s2.0-41149173996 10.1002/mds.21956
5. Schrag A., Jahanshahi M., Quinn N., How does Parkinson's disease affect quality of life? A comparison with quality of life in the general population. Movement Disorders 2000 15 1112 1118
6. Dubois B., Pillon B., Cognitive deficits in Parkinson's disease. Journal of Neurology 1997 244 1 2 8 2-s2.0-0031060220
7. Williams-Gray C. H., Evans J. R., Goris A., Foltynie T., Ban M., Robbins T. W., Brayne C., Kolachana B. S., Weinberger D. R., Sawcer S. J., Barker R. A., The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort. Brain 2009 132 11 2958 2969 2-s2.0-70350641659 10.1093/brain/awp245
8. Saxby B. K., Harrington F., McKeith I. G., Wesnes K., Ford G. A., Effects of hypertension on attention, memory, and executive function in older adults. Health Psychology 2003 22 6 587 591 2-s2.0-0345659250 10.1037/0278-6133.22.6.587
9. Knopman D., Boland L. L., Mosley T., Howard G., Liao D., Szklo M., McGovern P., Folsom A. R., Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology 2001 56 1 42 48 2-s2.0-0035830396
10. Gouw A. A., Seewann A., Van Der Flier W. M., Barkhof F., Rozemuller A. M., Scheltens P., Geurts J. J. G., Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations. Journal of Neurology, Neurosurgery and Psychiatry 2011 82 2 126 135 2-s2.0-78751574080 10.1136/jnnp.2009.204685
11. Wu W., Brickman A. M., Luchsinger J., Ferrazzano P., Pichiule P., Yoshita M., Brown T., Decarli C., Barnes C. A., Mayeux R., Vannucci S. J., Small S. A., The brain in the age of old: the hippocampal formation is targeted differentially by diseases of late life. Annals of Neurology 2008 64 6 698 706 2-s2.0-58149229589 10.1002/ana.21557
12. Beyer M. K., Aarsland D., Greve O. J., Larsen J. P., Visual rating of white matter hyperintensities in Parkinson's disease. Movement Disorders 2006 21 2 223 229 2-s2.0-33644956160 10.1002/mds.20704
13. Lee S.-J., Kim J.-S., Yoo J.-Y., Song I.-U., Kim B.-S., Jung S.-L., Yang D.-W., Kim Y.-I., Jeong D.-S., Lee K.-S., Influence of white matter hyperintensities on the cognition of patients with parkinson disease. Alzheimer Disease and Associated Disorders 2010 24 3 227 233 2-s2.0-77956413979 10.1097/WAD.0b013e3181d71a13
14. Sławek J., Wieczorek D., Derejko M., Dubaniewicz M., Brockhuis B., Sitek E., Wilczewska L., Roszmann A., Lass P., The influence of vascular risk factors and white matter hyperintensities on the degree of cognitive impairment in Parkinson's disease. Neurologia i Neurochirurgia Polska 2008 42 6 505 512 2-s2.0-64849110265
15. Jones J. D., Malaty I., Price C. C., Okun M. S., Bowers D., Health comorbidities and cognition in 1948 patients with idiopathic Parkinson's disease. Parkinsonism & Related Disorders 2012 18 1073 1078
16. Lezak M., Howieson D., Bigler E., Tranel D., Neuropsychological Assessment 2012 5th New York, NY, USA Oxford University Press
17. Hughes A. J., Daniel S. E., Kilford L., Lees A. J., Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. Journal of Neurology Neurosurgery and Psychiatry 1992 55 3 181 184 2-s2.0-0026514953
18. Fahn S., Elton R. L., UPDRS Development Committee, Unified Parkinson's disease rating scale. Recent Development Parkinson 1987 2 153 163
19. Tomlinson C. L., Stowe R., Patel S., Rick C., Gray R., Clarke C. E., Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Movement Disorders 2010 25 15 2649 2653 2-s2.0-78349261173 10.1002/mds.23429
20. Sheline Y. I., Barch D. M., Garcia K., Gersing K., Pieper C., Welsh-Bohmer K., Steffens D. C., Doraiswamy P. M., Cognitive function in late life Depression: relationships to depression severity, cerebrovascular risk factors and processing speed. Biological Psychiatry 2006 60 1 58 65 2-s2.0-33745204385 10.1016/j.biopsych.2005.09.019
21. Heaton R. K., Miller S. W., Taylor M. J., Grant I., Revised Comprehensive Norms for An expAnded Halstead-Reitan Battery: Demographically Adjusted Neuropsychological Norms for African American and Caucasian Adults 2004 Lutz, Fla, USA PAR
22. Charlson M., Szatrowski T. P., Peterson J., Gold J., Validation of a combined comorbidity index. Journal of Clinical Epidemiology 1994 47 11 1245 1251 2-s2.0-0027940266 10.1016/0895-4356(94)90129-5
23. Wilson P. W. F., Anderson K. M., Kannel W. B., Epidemiology of diabetes mellitus in the elderly. The Framingham Study. American Journal of Medicine 1986 80 5 A 3 9 2-s2.0-0022549353
24. Aronow W. S., Fleg J. L., Pepine C. J., ACCF/AHA, 2011 expert consensus document on hypertension in the elderly. Journal of the American College of Cardiology 2011 57 2037 2114
25. Litvan I., Goldman J. G., Tröster A. I., Schmand B. A., Weintraub D., Petersen R. C., Mollenhauer B., Adler C. H., Marder K., Williams-Gray C. H., Aarsland D., Kulisevsky J., Rodriguez-Oroz M. C., Burn D. J., Barker R. A., Emre M., Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines. Movement Disorders 2012 27 3 349 356 2-s2.0-84858298114 10.1002/mds.24893
26. Rothman K. J., No adjustments are needed for multiple comparisons. Epidemiology 1990 1 1 43 46 2-s2.0-0025031812
27. Goldstein D. S., Dysautonomia in Parkinson's disease: neurocardiological abnormalities. Lancet Neurology 2003 2 11 669 676 2-s2.0-0142219814 10.1016/S1474-4422(03)00555-6
28. Verdelho A., Madureira S., Ferro J. M., Basile A.-M., Chabriat H., Erkinjuntti T., Fazekas F., Hennerici M., O'Brien J., Pantoni L., Salvadori E., Scheltens P., Visser M. C., Wahlund L.-O., Waldemar G., Wallin A., Inzitari D., Differential impact of cerebral white matter changes, diabetes, hypertension and stroke on cognitive performance among non-disabled elderly. The LADIS study. Journal of Neurology, Neurosurgery and Psychiatry 2007 78 12 1325 1330 2-s2.0-36849030286 10.1136/jnnp.2006.110361
29. Woods S. P., Tröster A. I., Prodromal frontal/executive dysfunction predicts incident dementia in Parkinson's disease. Journal of the International Neuropsychological Society 2003 9 1 17 24 2-s2.0-0037249095 10.1017/ S1355617703910022
30. Nanhoe-Mahabier W., de Laat K. F., Visser J. E., Zijlmans J., de Leeuw F.-E., Bloem B. R., Parkinson disease and comorbid cerebrovascular disease. Nature Reviews Neurology 2009 5 10 533 541 2-s2.0-70349860000 10.1038/nrneurol.2009.136
31. Rose K. M., Couper D., Eigenbrodt M. L., Mosley T. H., Sharrett A. R., Gottesman R. F., Orthostatic hypotension and cognitive function: the atherosclerosis risk in communities study. Neuroepidemiology 2010 34 1 1 7 2-s2.0-70350641631 10.1159/000255459
32. Yap P. L. K., Niti M., Yap K. B., Ng T. P., Orthostatic hypotension, hypotension and cognitive status: early comorbid markers of primary dementia? Dementia and Geriatric Cognitive Disorders 2008 26 3 239 246 2-s2.0-54749101620 10.1159/000160955
33. Novak V., Hajjar I., The relationship between blood pressure and cognitive function. Nature Reviews Cardiology 2010 7 12 686 698 2-s2.0-78649444829 10.1038/nrcardio.2010.161
34. Kim J. S., Oh Y. S., Lee K. S., Kim Y. I., Yang D. W., Goldstein D. S., Association of cognitive dysfunction with neurocirculatory abnormalities in early Parkinson disease. Neurology 2012 79 13 1323 1331
35. Dalaker T. O., Larsen J. P., Dwyer M. G., Aarsland D., Beyer M. K., Alves G., Bronnick K., Tysnes O.-B., Zivadinov R., White matter hyperintensities do not impact cognitive function in patients with newly diagnosed Parkinson's disease. NeuroImage 2009 47 4 2083 2089 2-s2.0-67651017515 10.1016/j.neuroimage. 2009.06.020
36. Bohnen N. I., Albin R. L., White matter lesions in Parkinson disease. Nature Reviews Neurology 2011 7 4 229 236 2-s2.0-79953775516 10.1038/nrneurol.2011.21